Stock Performance and Market Context
The stock has been on a consistent decline over the past six trading sessions, shedding approximately 6.36% in value during this period. Today’s fall of 0.11% further extended this negative momentum, underperforming the healthcare services sector by 0.73%. Krsnaa Diagnostics is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling persistent bearish sentiment among market participants.
In contrast, the broader market has shown resilience. The Sensex opened 304.20 points higher and climbed further by 284.26 points to close at 82,814.38, a gain of 0.72%. The index remains just 4.04% shy of its 52-week high of 86,159.02, supported by strong performances from mega-cap stocks. Despite this positive market backdrop, Krsnaa Diagnostics has lagged significantly.
Financial Metrics and Profitability Trends
Over the last year, Krsnaa Diagnostics has delivered a total return of -14.33%, in stark contrast to the Sensex’s 11.01% gain and the BSE500’s 14.57% return. The stock’s 52-week high was Rs.891.8, highlighting the extent of the recent decline. The company’s latest quarterly results for December 2025 revealed a net profit after tax (PAT) of Rs.15.25 crores, representing a 27.9% decrease compared to the previous four-quarter average. This contraction in profitability has weighed on investor sentiment.
Interest expenses have risen notably, with the latest six-month figure at Rs.15.98 crores, up 21.89%. The operating profit to interest ratio for the quarter stands at 5.96 times, the lowest recorded, indicating increased financial costs relative to earnings before interest and tax. These factors have contributed to the company’s current Mojo Score of 38.0 and a Mojo Grade of Sell, which was downgraded from Strong Sell on 6 February 2026.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
Institutional Holding and Market Participation
Institutional investors have reduced their stake in Krsnaa Diagnostics by 0.6% over the previous quarter, now collectively holding 18.03% of the company’s shares. This decline in institutional participation may reflect a cautious stance given the company’s recent financial performance and stock price trajectory. Institutional investors typically possess greater analytical resources, and their reduced involvement often signals concerns about the company’s near-term prospects.
Valuation and Capital Structure
Despite the recent price weakness, Krsnaa Diagnostics maintains a relatively low average debt-to-equity ratio of 0.09 times, indicating limited leverage on its balance sheet. The company’s return on capital employed (ROCE) stands at 11%, which is considered attractive within its sector. Additionally, the enterprise value to capital employed ratio is 2, suggesting the stock is trading at a discount relative to its peers’ historical valuations.
Profit growth over the past year has been modest, with a 6.3% increase, while the price-to-earnings-to-growth (PEG) ratio is elevated at 4.4. This indicates that the stock’s price decline has outpaced earnings growth, contributing to its current valuation profile.
Holding Krsnaa Diagnostics Ltd from Healthcare Services? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Key Indicators
Krsnaa Diagnostics Ltd’s current market capitalisation grade is 3, reflecting its mid-cap status within the healthcare services sector. The stock’s recent downgrade in Mojo Grade from Strong Sell to Sell on 6 February 2026 aligns with the deteriorating financial metrics and price performance. The company’s share price has declined from its 52-week high of Rs.891.8 to the current low of Rs.621.3, a drop of approximately 30.4% over the period.
While the broader market and sector indices have shown resilience, Krsnaa Diagnostics continues to face headwinds as evidenced by its underperformance and weakening financial ratios. The stock’s trading below all major moving averages further underscores the prevailing negative momentum.
Market Outlook and Positioning
In the context of the healthcare services sector, Krsnaa Diagnostics’ valuation metrics suggest it is trading at a discount relative to peers, supported by a low debt burden and reasonable ROCE. However, the recent decline in profitability and rising interest expenses have contributed to the subdued market sentiment. Institutional investors’ reduced stake and the stock’s underperformance relative to the Sensex and BSE500 indices highlight the challenges faced by the company in maintaining investor confidence.
Overall, the stock’s fall to a 52-week low of Rs.621.3 reflects a combination of financial pressures and market dynamics that have weighed on its share price over the past year.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
